Momenta Pharmaceuticals, Inc. (MNTA) Social Stream

Momenta Pharmaceuticals, Inc. (MNTA): $52.48

0.01 (-0.02%)

POWR Rating

Component Grades








Add MNTA to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals




in industry

Featured Post From StockTwits About MNTA

Who will $NVS acquire next? This Wedbush Securities analyst has some suggestions:
"We had a bit of pickup in activity with a couple of gene therapy companies getting bought in the past year or so, with Audentes and Nightstar getting purchased. There was a bigger acquisition going further back now with Lilly (NYSE: $LLY) buying Loxo Oncology, in the targeted oncology space. Recently, Johnson & Johnson (NYSE: $JNJ) put a bid for Momenta Pharmaceuticals (NASDAQ: $MNTA), a multibillion-dollar bid that got people’s attention.

So hopefully, there’ll be a bit of a pickup. It’s hard to see why there wouldn’t be given many more small- and mid-cap biotech companies getting into the later stages of development, in addition to the free money situation that we find ourselves in, where larger corporations like a JNJ or Novartis (NYSE:NVS) or Pfizer (NYSE: $PFE) can essentially borrow at 0%..."
dfree810, published October 20, 2020

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!